Article

GARD: Genomic Data based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation

2026-01-16

Abstract excerpt

<h4>Background/Objectives</h4> Head and neck cancer (HNC) represents the seventh most common cancer diagnosis globally, yet current treatments, including surgery, radiation, and immunotherapy, have shown limited improvement in outcomes. Drug repurposing offers a cost-effective strategy to identify new therapeutic options by leveraging existing medications with known safety profiles. Within this study we developed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fe2d252e-38ed-5076-bceb-c3250d0232a0
DOI: 10.64898/2026.01.15.699561

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

GARD: Genomic Data based Drug Repurposing in Head and Neck Cancer with Large Language Model ValidationDOI 10.64898/2026.01.15.699561Read

Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databasesSemantic proximity Read

A multi-omics approach to identify prognostic subtypes and therapeutic targets in head and neck squamous cell carcinomaSemantic proximity Read

Identifying Biomarkers and Therapeutic Targets by Multiomic Analysis for HNSCC: Precision Medicine and Healthcare ManagementSemantic proximity Read

CanSeer: A Method for Development and Clinical Translation of Personalized Cancer TherapeuticsSemantic proximity Read

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read

The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapiesSemantic proximity Read

Novel insights into head and neck cancer using next-generation "omic" technologies.Semantic proximity Read

HNCDrugResDb: a platform for deciphering drug resistance in head and neck cancersSemantic proximity Read

HPV16 Status Predicts Differential Interactome in Head and Neck Squamous Cell Carcinoma: Potential Prognostic Biomarkers and Therapeutics in Framework of 3P MedicineSemantic proximity Read

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19Semantic proximity Read

Integrating single-cell RNA sequencing, WGCNA, and machine learning to identify key biomarkers in hepatocellular carcinomaSemantic proximity Read

Computationally Repurposing Drugs for Breast Cancer Subtypes Using a Network-Based ApproachSemantic proximity Read